Back to User profile » Dr Michael P. Ero
Paper published by Dr Michael P. Ero:
Clinical Trial Report
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/ug0zwgf4bV0/1.jpg)
Jensen GS, Lenninger M, Ero MP, Benson KF
Integrated Blood Pressure Control 2016, 9:95-104
Published Date: 13 October 2016